117 related articles for article (PubMed ID: 20404523)
1. TACCing on new functions for the TSC2 tumor suppressor.
Golemis EA
Cell Cycle; 2010 Apr; 9(7):1232-3. PubMed ID: 20404523
[No Abstract] [Full Text] [Related]
2. Similarity of balloon cells in focal cortical dysplasia to giant cells in tuberous sclerosis.
Jozwiak J; Kotulska K; Jozwiak S
Epilepsia; 2006 Apr; 47(4):805. PubMed ID: 16650151
[No Abstract] [Full Text] [Related]
3. The genomic landscape of tuberous sclerosis complex.
Martin KR; Zhou W; Bowman MJ; Shih J; Au KS; Dittenhafer-Reed KE; Sisson KA; Koeman J; Weisenberger DJ; Cottingham SL; DeRoos ST; Devinsky O; Winn ME; Cherniack AD; Shen H; Northrup H; Krueger DA; MacKeigan JP
Nat Commun; 2017 Jun; 8():15816. PubMed ID: 28643795
[TBL] [Abstract][Full Text] [Related]
4. Constellation of five facial features of tuberous sclerosis in a child with a TSC2 1808A>G mutation.
Hardy R; Shepherd CW; Donnelly DE; McKee SA; Morrison PJ
Oncologist; 2012; 17(7):925-6. PubMed ID: 22707510
[TBL] [Abstract][Full Text] [Related]
5. A novel TSC2 mutation in a Korean patient with tuberous sclerosis complex.
Hu HJ; Chung YJ; Yoo HW; Kim YH; Eom TH
Neurol Sci; 2014 Sep; 35(9):1487-9. PubMed ID: 24770934
[No Abstract] [Full Text] [Related]
6. Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds.
Wentink M; Nellist M; Hoogeveen-Westerveld M; Zonnenberg B; van der Kolk D; van Essen T; Park SM; Woods G; Cohn-Hokke P; Brussel W; Smeets E; Brooks A; Halley D; van den Ouweland A; Maat-Kievit A
Clin Genet; 2012 May; 81(5):453-61. PubMed ID: 21332470
[TBL] [Abstract][Full Text] [Related]
7. Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber.
Jansen FE; Notenboom RG; Nellist M; Goedbloed MA; Halley DJ; de Graan PN; van Nieuwenhuizen O
Neurology; 2004 Oct; 63(7):1293-5. PubMed ID: 15477556
[TBL] [Abstract][Full Text] [Related]
8. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation (insTCCG) in the TSC2 gene in a Chinese patient with tuberous sclerosis complex.
Yuan CD; Chang XL; Gao M; Xiao FL; Wu YQ; Liu Q; Shen SK; Liu JL; Du WH; Liu JJ; Yang S; Zhang XJ; Zhou FS; Fang QY
J Dermatol Sci; 2008 Jan; 49(1):92-4. PubMed ID: 17888633
[No Abstract] [Full Text] [Related]
10. Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis.
Mayer K; Goedbloed M; van Zijl K; Nellist M; Rott HD
J Med Genet; 2004 May; 41(5):e64. PubMed ID: 15121792
[No Abstract] [Full Text] [Related]
11. Tuberous sclerosis complex: from Drosophila to human disease.
Pan D; Dong J; Zhang Y; Gao X
Trends Cell Biol; 2004 Feb; 14(2):78-85. PubMed ID: 15102439
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis complex: molecular pathogenesis and animal models.
Piedimonte LR; Wailes IK; Weiner HL
Neurosurg Focus; 2006 Jan; 20(1):E4. PubMed ID: 16459994
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex: genetics to pathogenesis.
Narayanan V
Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
[TBL] [Abstract][Full Text] [Related]
14. Aberrant beta-catenin signaling in tuberous sclerosis.
Mak BC; Kenerson HL; Aicher LD; Barnes EA; Yeung RS
Am J Pathol; 2005 Jul; 167(1):107-16. PubMed ID: 15972957
[TBL] [Abstract][Full Text] [Related]
15. Interaction of TACC3 and TSC2 at the nuclear envelope and mitotic structures.
Ertych N; Bastians H
Cell Cycle; 2010 Apr; 9(7):1233. PubMed ID: 20404524
[No Abstract] [Full Text] [Related]
16. Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex.
Hoogeveen-Westerveld M; Wentink M; van den Heuvel D; Mozaffari M; Ekong R; Povey S; den Dunnen JT; Metcalfe K; Vallee S; Krueger S; Bergoffen J; Shashi V; Elmslie F; Kwiatkowski D; Sampson J; Vidales C; Dzarir J; Garcia-Planells J; Dies K; Maat-Kievit A; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2011 Apr; 32(4):424-35. PubMed ID: 21309039
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis: from tubers to mTOR.
Kwiatkowski DJ
Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
[TBL] [Abstract][Full Text] [Related]
18. A Chinese tuberous sclerosis complex family and a novel tuberous sclerosis complex-2 mutation.
Luo R; Cai Q; Mu D
Chin Med J (Engl); 2015 Jan; 128(1):128-30. PubMed ID: 25563326
[No Abstract] [Full Text] [Related]
19. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
Sampson JR
Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
[TBL] [Abstract][Full Text] [Related]
20. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]